Skip to main content

Table 2 Anticancer activities of Zingiber officinale extracts against MCF-7 and MDA-MB-231 cell lines (determined by the MTT assay at concentration 37.5 μg/ml)

From: RETRACTED ARTICLE: In vitro antioxidant and anticancer activity of young Zingiber officinale against human breast carcinoma cell lines

CO2 (μmol/mol)

Varieties

Parts

MCF-7

MDA-MB-231

 

Fulbaria

Aerial parts

Rhizomes

59.65 ± 2.55b

57.56 ± 1.68b

63.31 ± 1.85e

69.41 ± 2.30b

400

    
 

Syedpuri

Aerial parts

Rhizomes

50.65 ± 0.56e

56.98 ± 1.74b

58.12 ± 1.09a

66.61 ± 2.31b,e

 

Fulbaria

Aerial parts

Rhizomes

40.37 ± 1.46c

48.97 ± 1.04e

48.16 ± 1.03c

44.35 ± 1.86d

800

    
 

Syedpuri

Aerial parts

Rhizomes

44.93 ± 1.53a

39.01 ± 2.1c

43.02 ± 1.99d

40.16 ± 2.42f

Positive control

Tamoxifen

24.9 ± 1.6

26.70 ± 2.11

  1. All analyses are the mean of triplicate measurements ± standard deviation. Means not sharing a common letter were significantly different at P ≤ 0.05.
  2. Results expressed in percent of cell viability.